Topical finasteride is the same active ingredient as the oral pill, formulated as a solution or gel that you apply to the scalp. The idea is straightforward. Deliver the drug where hair follicles are miniaturizing, lower the dihydrotestosterone (DHT) that drives male pattern hair loss locally, and limit how much reaches the rest of the body. For men who want finasteride's results but worry about side effects, this is the version worth understanding.
How topical finasteride works
Male pattern hair loss is driven by DHT, a hormone the enzyme 5-alpha-reductase makes from testosterone. DHT binds to receptors in genetically sensitive scalp follicles and shrinks them over successive growth cycles until the hair is too fine to matter. Finasteride blocks 5-alpha-reductase, so less DHT is produced.
Oral finasteride does this throughout the body. Plasma DHT drops roughly 70 percent on a 1 mg daily dose. Topical finasteride targets the scalp instead. It lowers DHT in the skin and follicles directly, and because less drug enters the bloodstream, the drop in plasma DHT is smaller. That is the entire premise. Same enzyme blocked, different exposure profile.
One detail matters here. Less systemic absorption is not zero systemic absorption. Finasteride applied to the scalp does cross into the blood. Studies consistently measure a meaningful reduction in serum DHT with the topical form, just less than oral. So the honest framing is reduced systemic exposure, not eliminated.
What the evidence shows
The most useful data comes from a randomized, double-blind trial published in JAMA Dermatology in 2022 by Piraccini and colleagues. It compared topical finasteride spray against oral finasteride and placebo in men with androgenetic alopecia. Two findings stand out. Topical finasteride produced a change in hair count that was comparable to the oral form and clearly better than placebo. And serum DHT was suppressed far less with the topical version, with average plasma DHT reduction well under what oral dosing produces.
In plain terms, the trial suggested you can get oral-range hair benefit while exposing the body to less of the drug. That is a genuinely useful result for the right patient. It rests largely on a single trial, though. The evidence base for topical finasteride is thinner than the decades of data behind the oral pill, and formulations differ between products, which makes head-to-head comparison harder.
What topical finasteride does not do is rescue hair that is already gone. Like every DHT blocker, it slows and partially reverses miniaturization in follicles that are still alive. Bald scalp with no follicular activity will not regrow.
Who topical finasteride suits
This form tends to fit a specific kind of patient.
- Men with early to moderate male pattern hair loss who want a DHT blocker but are cautious about systemic side effects.
- Men who tried oral finasteride, saw benefit, but want to test whether a lower systemic dose maintains results.
- Men who prefer applying a treatment topically alongside minoxidil rather than taking another daily pill.
It is a weaker fit for men with very advanced loss, who often need a frank conversation about realistic outcomes, and for anyone unwilling to apply a product to the scalp consistently. Adherence matters more than the molecule. A topical that sits in the cabinet does nothing.
If you are weighing topical finasteride against a stronger oral agent, our explainer on dutasteride versus finasteride covers where the more potent option fits.
Formulation and how it is combined
Topical finasteride is usually compounded, meaning a pharmacy prepares it to a clinician's specification rather than it coming as a single mass-market product. No topical finasteride is currently FDA-approved in the United States, so it is available only as a compounded preparation. Concentrations vary, commonly in the range of 0.1 to 0.25 percent. It is frequently combined with topical minoxidil in one solution, which pairs a DHT blocker with a separate mechanism that extends the growth phase and improves blood flow to the follicle. The two address hair loss through different pathways, which is why clinicians often use them together.
Because formulations are not standardized, the product a KAYU clinician selects, the vehicle, and the application schedule all factor into how much drug reaches the scalp versus the bloodstream. This is not a one-size dose.
Realistic timeline
Hair grows slowly, and so does the response to any treatment that works on the growth cycle. Expect the first signs of stabilization, meaning shedding slows, around three months. Visible thickening or regrowth, where it happens, typically shows by six months, with fuller results assessed at a year. Stopping reverses the gains within several months because DHT suppression ends and miniaturization resumes. This is an ongoing therapy, not a course you finish.
A short note on shedding. Some men notice increased shedding in the first weeks. This is usually follicles cycling into a new growth phase, not the treatment failing, though it should be reviewed if it is severe or prolonged.
Safety and handling
The side effect profile of topical finasteride is generally milder than oral because systemic exposure is lower, but the same categories apply, including the possibility of sexual side effects in a minority of users. Lower risk is not no risk. Report any persistent changes to your clinician.
Finasteride is not for women who are pregnant or may become pregnant. It is classified by the FDA as pregnancy category X because it can interfere with development of the genitals in a male fetus. With a topical, handling precautions matter as much as the dose. The treated scalp should be dry before contact, and a pregnant person should not handle the solution or come into contact with freshly applied product. Women considering finasteride for their own hair loss should read our dedicated guide on finasteride for women, where the safety rules are different and stricter.
Topical finasteride, like the oral form, can lower PSA, the marker used in prostate cancer screening. Tell any clinician ordering a PSA that you use finasteride so the result can be interpreted correctly.
How KAYU approaches it
Hair loss treatment is individual. The KAYU intake panel and a clinician review your pattern of loss, history, and goals before recommending a formulation, because the right concentration and whether to combine with minoxidil depend on you, not a default. KAYU is a telehealth practice licensed in California. You can read more on our hair loss page and the broader hair loss condition overview, or explore how DHT and other hormones connect across our hormones resources.
Take the 2-minute KAYU assessment and a California-licensed clinician will review your goals and labs.
This article is educational. It is not medical advice and does not substitute for a provider-patient relationship. A KAYU clinician will evaluate your individual history before recommending any treatment.